Back to Search
Start Over
Experience of anti-Immunoglobulin E-therapy in children with chronic inducible urticaria
- Source :
- Russian Journal of Allergy. 18:135-139
- Publication Year :
- 2021
- Publisher :
- Farmarus Print Media, 2021.
-
Abstract
- Based on clinical cases, the authors present their own experience of successful anti-Immunoglobulin E-therapy using omalizumab at 300 mg every 4 weeks with clinical manifestations of chronic inducible urticaria in children, such as cholinergic urticaria and cold urticaria, which was observed without chronic spontaneous urticaria symptoms. Concurrently, the patient with cold urticaria had a complete response after the first injection, with a total course of treatment of 6 months, whereas the patient with cholinergic urticaria did not immediately receive therapy and needed a 12-month course of treatment with strict administration regimen adherence for 4 weeks. All patients have achieved sustained disease remission.
Details
- ISSN :
- 2686682X and 18108830
- Volume :
- 18
- Database :
- OpenAIRE
- Journal :
- Russian Journal of Allergy
- Accession number :
- edsair.doi...........2e603789f9d35508d2b8a0a909fdf6ce